前沿生物-U
(688221)
| 流通市值：62.67亿 | | | 总市值：62.67亿 |
| 流通股本：3.75亿 | | | 总股本：3.75亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 313,296,180.72 | 297,131,734.61 | 123,386,656.86 | 103,373,939.22 |
| 营业总成本 | 179,728,405.4 | 74,623,130.61 | 378,879,481.97 | 262,354,974.69 |
| 其他经营收益 | | | | |
| 营业利润 | 148,964,338.45 | 227,645,045.69 | -267,720,614.09 | -159,475,988.33 |
| 利润总额 | 148,929,627.03 | 227,393,754.18 | -268,053,032.03 | -159,808,526.07 |
| 净利润 | 148,929,627.03 | 227,393,754.18 | -268,053,032.03 | -159,808,526.07 |
| 每股收益 | | | | |
| 其他综合收益 | 78,596.2 | 40,776.3 | 15,381.27 | 17,530.76 |
| 综合收益总额 | 149,008,223.23 | 227,434,530.48 | -268,037,650.76 | -159,790,995.31 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 1,193,547,073.21 | 1,287,817,815.85 | 1,004,818,169.9 | 1,055,901,026.23 |
| 非流动资产: | | | | |
| 非流动资产合计 | 552,036,755.04 | 562,633,115.57 | 573,492,344.21 | 581,489,363.29 |
| 资产总计 | 1,745,583,828.25 | 1,850,450,931.42 | 1,578,310,514.11 | 1,637,390,389.52 |
| 流动负债: | | | | |
| 流动负债合计 | 240,798,092.39 | 363,781,884.82 | 410,339,338.82 | 390,421,353.95 |
| 非流动负债: | | | | |
| 非流动负债合计 | 470,915,454.88 | 378,391,172.08 | 291,102,383.29 | 265,448,633.98 |
| 负债合计 | 711,713,547.27 | 742,173,056.9 | 701,441,722.11 | 655,869,987.93 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 1,033,870,280.98 | 1,108,277,874.52 | 876,868,792 | 981,520,401.59 |
| 股东权益合计 | 1,033,870,280.98 | 1,108,277,874.52 | 876,868,792 | 981,520,401.59 |
| 负债和股东权益合计 | 1,745,583,828.25 | 1,850,450,931.42 | 1,578,310,514.11 | 1,637,390,389.52 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 381,894,352.02 | 328,879,067.99 | 119,691,620.15 | 88,991,128.83 |
| 经营活动现金流出小计 | 201,005,386.4 | 110,999,278.73 | 346,279,922.92 | 240,780,717.43 |
| 经营活动产生的现金流量净额 | 180,888,965.62 | 217,879,789.26 | -226,588,302.77 | -151,789,588.6 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 1,350,289,913.66 | 651,741,137.27 | 3,013,117,222.18 | 2,479,193,958.12 |
| 投资活动现金流出小计 | 1,313,844,888.43 | 912,280,941.05 | 2,840,434,170.78 | 2,423,745,665.31 |
| 投资活动产生的现金流量净额 | 36,445,025.23 | -260,539,803.78 | 172,683,051.4 | 55,448,292.81 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 242,258,756.4 | 142,258,756.4 | 361,850,023.44 | 289,559,879.25 |
| 筹资活动现金流出小计 | 236,767,285.25 | 82,281,460.41 | 386,272,934.27 | 344,776,026.5 |
| 筹资活动产生的现金流量净额 | 5,491,471.15 | 59,977,295.99 | -24,422,910.83 | -55,216,147.25 |
| 汇率变动对现金及现金等价物的影响 | 57,156.55 | -60,241.86 | -47,436.25 | -26,046.19 |
| 现金及现金等价物净增加额 | 222,882,618.55 | 17,257,039.61 | -78,375,598.45 | -151,583,489.23 |
| 期末现金及现金等价物余额 | 393,226,977.92 | 187,601,398.98 | 170,344,359.37 | 97,136,468.59 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | 222,882,618.55 | - | -78,375,598.45 | - |
最新报告期：2026-09-03| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 国联民生 | 张金洋,胡偌碧,郭广洋 | 0.07 | -0.26 | -0.24 | 2026-09-03 |
| 开源证券 | 余汝意,巢舒然 | -0.08 | -0.51 | -0.57 | 2026-09-01 |